Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02872207 · ClinicalTrials.gov registry record · NA
Evaluation of the Stinging Potential in Human Eyes
A NA study of Sunscreen Agents, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT02872207 is a NA study of Sunscreen Agents that has completed, run by Bayer. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02872207, a NA study of Sunscreen Agents, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study was to compare the human eye stinging potential of experimental formulas and an industry standard shampoo mixture. The study was conducted under the supervision of a Board Certified Ophthalmologist.
Conditions Studied
Interventions
- DRUG Control
- DRUG BAY 987516 (Y65-122)
- DRUG BAY 987516 (Y65-118)
Study Locations (1)
Florida
- - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-02-21 |
| Est. Completion | 2015-02-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02872207
The ClinicalTrials.gov registry entry for NCT02872207 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sunscreen Agents appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT02872207 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02872207 about?
NCT02872207 is a clinical study titled "Evaluation of the Stinging Potential in Human Eyes". The objective of this study was to compare the human eye stinging potential of experimental formulas and an industry standard shampoo mixture. The study was conducted under the supervision of a Board Certified Ophthalmologist.
What is the current status of trial NCT02872207?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-02-21. Estimated completion is 2015-02-22.
What conditions does trial NCT02872207 study?
This clinical trial studies the following conditions: Sunscreen Agents.
What interventions are being tested in trial NCT02872207?
The interventions under investigation include: Control (DRUG), BAY 987516 (Y65-122) (DRUG), BAY 987516 (Y65-118) (DRUG).
Who is sponsoring clinical trial NCT02872207?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02872207 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sunscreen Agents
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.